Alternatives to Profluent Bio

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

AI research lab developing frontier models for protein design and biological discovery.

Biotech company developing next-generation gene writing tools for advanced therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI-powered drug discovery and development platform for biologics.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Biotechnology company developing novel immunotherapies for cancer.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Advance every cancer decision.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.